What does CUSIP 379577208 represent in this 13F holders report?

CUSIP 379577208 is the security identifier for GMED - GLOBUS MEDICAL INC - Class A Stock used to aggregate holder disclosures.

How many institutions held GMED - GLOBUS MEDICAL INC - Class A Stock in Q4 2021?

367 institutional investors reported GMED - GLOBUS MEDICAL INC - Class A Stock for Q4 2021. Use the holders table for investor-level position and value details.

GLOBUS MEDICAL INC - Class A Stock (GMED)

CUSIP: 379577208

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Class A Stock
Shares outstanding: 115,244,363
Total 13F shares: 68,345,177
Share change: +235,657
Total reported value: $4,935,105,853
Put/Call ratio: 63%
Price per share: $72.20
Number of holders: 367
Value change: +$7,508,095
Number of buys: 172
Number of sells: 173

Quarterly Holders Quick Answers

What is CUSIP 379577208?
CUSIP 379577208 identifies GMED - GLOBUS MEDICAL INC - Class A Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 379577208:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of GMED - GLOBUS MEDICAL INC - Class A Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	6.3%	7,313,502	$560,360,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	6.3%	7,300,466	$559,362,000	—	30 Sep 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	5%	5,768,964	$442,018,000	—	30 Sep 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.8%	3,244,691	$248,608,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	1.8%	2,117,014	$162,206,000	—	30 Sep 2021	13F
Capital Research Global Investors	13F	Company	1.7%	1,958,807	$150,084,000	—	30 Sep 2021	13F
RTW INVESTMENTS, LP	13F	Company	1.4%	1,670,811	$128,018,000	—	30 Sep 2021	13F
Champlain Investment Partners, LLC	13F	Company	1.4%	1,634,235	$125,215,000	—	30 Sep 2021	13F
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC	13F	Company	1.3%	1,547,605	$118,578,000	—	30 Sep 2021	13F
AXA S.A.	13F	Company	1.3%	1,530,920	$117,299,000	—	30 Sep 2021	13F
GW&K Investment Management, LLC	13F	Company	1.3%	1,488,750	$114,068,000	—	30 Sep 2021	13F
Marathon Asset Management Ltd	13F	Company	1.2%	1,360,788	$104,267,000	—	30 Sep 2021	13F
GENEVA CAPITAL MANAGEMENT LLC	13F	Company	1.1%	1,248,074	$95,627,000	—	30 Sep 2021	13F
Invesco Ltd.	13F	Company	1.1%	1,239,028	$94,933,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.96%	1,111,768	$85,183,000	—	30 Sep 2021	13F
Van Berkom & Associates Inc.	13F	Company	0.82%	946,997	$72,559,000	—	30 Sep 2021	13F
FMR LLC	13F	Company	0.82%	939,322	$71,971,000	—	30 Sep 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.76%	872,993	$66,889,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.72%	829,622	$63,565,000	—	30 Sep 2021	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.62%	710,082	$56,473,000	—	30 Sep 2021	13F
Bellevue Group AG	13F	Company	0.63%	729,420	$55,888,000	—	30 Sep 2021	13F
Polar Capital Holdings Plc	13F	Company	0.62%	714,037	$54,710,000	—	30 Sep 2021	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.59%	680,394	$52,131,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.53%	615,910	$47,191,000	—	30 Sep 2021	13F
PARADIGM CAPITAL MANAGEMENT INC/NY	13F	Company	0.53%	615,000	$47,122,000	—	30 Sep 2021	13F
Pembroke Management, LTD	13F	Company	0.52%	601,447	$46,083,000	—	30 Sep 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.52%	594,332	$45,537,000	—	30 Sep 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.51%	589,533	$45,177,000	—	30 Sep 2021	13F
Consonance Capital Management LP	13F	Company	0.51%	589,100	$45,137,000	—	30 Sep 2021	13F
NORGES BANK	13F	Company	0.51%	587,257	$44,996,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.47%	544,688	$41,734,000	—	30 Sep 2021	13F
LOOMIS SAYLES & CO L P	13F	Company	0.44%	504,174	$38,630,000	—	30 Sep 2021	13F
Boston Trust Walden Corp	13F	Company	0.43%	490,035	$37,546,000	—	30 Sep 2021	13F
ROYAL BANK OF CANADA	13F	Company	0.37%	428,897	$32,862,000	—	30 Sep 2021	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.36%	420,462	$32,216,000	—	30 Sep 2021	13F
Legal & General Group Plc	13F	Company	0.3%	350,612	$26,864,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.28%	318,898	$24,434,000	—	30 Sep 2021	13F
FIRST TRUST ADVISORS LP	13F	Company	0.27%	314,262	$24,079,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.27%	310,137	$23,763,000	—	30 Sep 2021	13F
FULLER & THALER ASSET MANAGEMENT, INC.	13F	Company	0.25%	285,307	$21,860,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.25%	284,839	$21,824,000	—	30 Sep 2021	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.23%	270,770	$20,746,000	—	30 Sep 2021	13F
SEGALL BRYANT & HAMILL, LLC	13F	Company	0.23%	268,314	$20,557,000	—	30 Sep 2021	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.23%	263,721	$20,206,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.22%	257,401	$19,722,000	—	30 Sep 2021	13F
Swedbank AB	13F	Company	0.22%	255,000	$19,538,100	—	30 Sep 2021	13F
Retirement Systems of Alabama	13F	Company	0.22%	253,687	$19,437,000	—	30 Sep 2021	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.22%	253,186	$19,399,000	—	30 Sep 2021	13F
Aberdeen Group plc	13F	Company	0.19%	222,707	$17,365,000	—	30 Sep 2021	13F
Vident Investment Advisory, LLC	13F	Company	0.18%	206,693	$15,836,000	—	30 Sep 2021	13F

Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2021

As of 31 Dec 2021, GLOBUS MEDICAL INC - Class A Stock (GMED) was held by 367 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 68,345,177 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Capital Research Global Investors, Champlain Investment Partners, LLC, RTW INVESTMENTS, LP, AXA S.A., and KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC. This page lists 368 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

380

Q4 2021 holders

367

Holder diff

-13

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.